Table 1.
Reported cases of mesalamine-induced EPE
| Cases | Age/sex | Indication | Daily dose (mg) | Time period to first episode of EPE |
Episodes (n) | Lung infiltrates | Treatment |
| Sesin et al3 | 73/F | UC | 2400 | 2–3 months | 2 | Yes | Discontinued |
| Trisolini et al4 | 38/M | None | 2400 | 2–4 weeks | 1 | Yes | Discontinued and steroids |
| Kim et al19 | 30/F | UC | 1000 | 3 weeks | 1 | Yes | Discontinued |
| Lalani et al20 | 61/M | UC | 3200 | Not available | 1 | No | Discontinued |
| This study | 45/F | UC | 1000 | 1 month | 1 | No | Discontinued |
EPE, eosinophilic pleural effusion; F, female; M, male; UC, ulcerative colitis.